Journal
Current Medical Research and Opinion
Publication Date
11-1-2023
Volume
39
Issue
11
First Page
1505
Last Page
1511
Document Type
Open Access Publication
DOI
10.1080/03007995.2023.2262381
Rights and Permissions
Ghia P, Barnes G, Yang K, Tam CS, Robak T, Brown JR, Kahl BS, Tian T, Szeto A, Paik JC, Shadman M. Health-related quality-of-life in treatment-naive CLL/SLL patients treated with zanubrutinib versus bendamustine plus rituximab. Curr Med Res Opin. 2023 Nov;39(11):1505-1511. doi: 10.1080/03007995.2023.2262381. © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
Recommended Citation
Ghia, Paolo; Barnes, Gisoo; Yang, Keri; Tam, Constantine S; Robak, Tadeusz; Brown, Jennifer R; Kahl, Brad S; Tian, Tian; Szeto, Andy; Paik, Jason C; and Shadman, Mazyar, "Health-related quality-of-life in treatment-naive CLL/SLL patients treated with zanubrutinib versus bendamustine plus rituximab." Current Medical Research and Opinion. 39, 11. 1505 - 1511. (2023).
https://digitalcommons.wustl.edu/oa_4/4145
Additional Links
Supplemental material is available for this article at publisher site.
